In this episode of the Psychedelic Spotlight podcast, Psychedelic Investor, James Hallifax interviews Matt Stang, Co-Founder and CEO of Delic Corp. Delic is a psychedelic medicines company focused on bringing psychedelic wellness to the mainstream through their infrastructure of ketamine therapy clinics; the largest in the U.S.
You can find Delic Corp trading on the Canadian Securities Exchange under the symbol $DELC and on the American OTC market under the symbol $DELCF.
*To learn more about Delic, visit their website: DelicCorp.com
*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.com
